A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to ...

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone for preventing ischemic strokes in patients with acute noncardioembolic ...

Please provide your email address to receive an email when new articles are posted on . Societies issued new guidelines for the screening and treatment of stroke. The new document provides ...

As stroke risk rises for women as they age — especially after menopause — a new long-term study suggests that what they eat may play a powerful role in lowering that risk. Stroke is a leading cause of ...

“This update brings the most important advances in stroke care from the last decade directly into practice,” Shyam Prabhakaran, MD, chair of the writing group, said in a statement. “New ...

If you regularly deliver the same presentation, you may need to make small adjustments for different audiences or time constraints–for example, by omitting some slides. In PowerPoint, you can save ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...

Add Yahoo as a preferred source to see more of our stories on Google. Tune into The Daily Beast Podcast on Sunday, Jan. 25 at 2 p.m. when Dr. Bruce Davidson joins host Joanna Coles for a stark ...

Deaths from both causes are down, but they still eclipse all other causes, according to new statistics. By Nina Agrawal Despite gains in treatment, cardiovascular disease remains the leading cause of ...

When Donald Trump won his second term in the White House, he was the oldest man in the history of the United States to do so. Assuming he serves for his entire term, he’ll be 82 years and seven months ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...